Potential risks of common MS treatmentIn one of the most comprehensive studies to date, researchers have identified potential adverse reactions of a commonly used multiple sclerosis drug. … read morePosted At: Science Daily
Viruses in chronic progressive neurologic diseaseMultiple Sclerosis Journal, Volume 24, Issue 1, Page 48-52, January 2018. … read morePosted At: MS Journal
Hippotherapy for patients with multiple sclerosis: A multicenter randomized controlled trial (MS-HIPPO)
Hippotherapy for patients with multiple sclerosis: A multicenter randomized controlled trial (MS-HIPPO)Multiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Insights into microbiome research 1: How to choose appropriate controls for a microbiome study in MS?
Insights into microbiome research 1: How to choose appropriate controls for a microbiome study in MS?Multiple Sclerosis Journal, Volume 24, Issue 10, Page 1278-1279, September 2018. … read morePosted At: MS Journal
Colorado Gov. John Hickenlooper Honored for Commitment to Changing the World for People Living with/About-the-Society/News/Colorado-Gov-John-Hickenlooper-Honored-for-Commit … read morePosted At: National MS Society
Join Our Mailing List
- Retinal degeneration is associated with brain volume reduction and prognosis in radiologically isolated syndrome
- False hepatitis B and C viral serologies in patients with multiple sclerosis receiving high-dose biotin
- What to know about marijuana and multiple sclerosis
- Using graphene to detect ALS, other neurodegenerative diseasesPosted At: Science Daily
- Is the ketogenic diet good for multiple sclerosis?
- What is Lhermitte’s sign?
- What to know about multiple sclerosis and mood swings
- FDA Issues Warning About Rare Risk of Stroke and Artery Wall Tears with Use of Lemtrada Posted At: National MS Society
- Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria
- Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium